Search
for
Sort by
Research 841–870 of 1000+
- The Rotterdam Study: 2010 objectives and design update
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Methotrexate for maintenance of remission in ulcerative colitis
- Guidelines on the use of finasteride in androgenetic alopecia
- Biomembrane-Based Nanostructure- and Microstructure-Loaded Hydrogels for Promoting Chronic Wound Healing
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
- The mind-body problem; three equations and one solution represented by immaterial-material data
- An update of polycystic ovary syndrome: causes and therapeutics options
- A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Azathioprine‐induced severe myelosuppression accompanied by massive hair loss and painful oral ulcer in an autoimmune hepatitis patient with <i>NUDT15</i> minor variant: A case report
- Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults
- Tackling Adverse Effects
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Genetic analysis of 5 α reductase type 2 enzyme in relation to oxidative stress in cases of androgenetic alopecia in a sample of egyptian population
- ENZYMES
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
- SRD5A2 and emerging therapies in androgen-driven disorders
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Concomitant Alopecia Areata and Profound Bone Marrow Suppression: An Unusual Manifestation of Azathioprine Toxicity
- The interaction between finasteride and corticosterone levels: implications for depression-, and anxiety-like behavior and hippocampal synaptic plasticity in male rats
- Effectiveness and Adverse Drug Reaction Mechanisms Associated with Valproic Acid Use: A Cross-Sectional Prospective Study in Indonesia
- Post-finasteride syndrome - a true clinical entity?
- Is polymorphism of the STK11 gene a predictor of response to metformin in polycystic ovarian syndrome?
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders